SmallCapVoice.com

Archive for the ‘Interviews’ Category

Podcast: Download (Duration: 18:13 — 16.7MB)

Robert Bryson, Connected Lyfe’s president and CEO, called into SmallCapVoice.com to discuss the recent news, the management team and the business model and market for Lyfe Communications, Inc. (OTCBB:LYFE). Connected Lyfe is developing, deploying and operating a converged network services platform for the next generation of entertainment and communications. For more information visit www.connectedlyfe.com. The Company recently announced the purchase of all data provisioning rights to Ygnition Network’s multi-family residential communities in Los Angeles, San Francisco, San Diego, Phoenix, Houston, Dallas, and Seattle. Connected Lyfe’s services are currently available to individual households and multi-family communities in 11 Utah cities. Today’s news marks the expansion of Connected Lyfe’s ultra high-speed Internet platform to 73 residential communities representing 24,000 potential units.

Podcast: Download (Duration: 13:13 — 12.1MB)

Rick Kundrat, CEO for NuVim, Inc. (Pink Sheets: NUVM) called into SmallCapvoice.com to discuss how NuVim® is a one of a kind beverage. NuVim® contains lactose free whey protein, a prebiotic fiber based on extensive research and development that spanned over 30 years, and essential minerals and vitamins. NuVim® helps maintain a strong immune system, increase vitamin and mineral absorption, especially calcium for bone and muscle health, and improves digestion. With only 45 calories per 8 ounce serving and its nutritional values, NuVim® could be considered the “Best Thing You Can Drink.” After drinking NuVim® for 30 days, NuVim® guarantees you will “Feel the Difference.” NuVim® has no high fructose corn syrup, no lactose, no cholesterol, no fat, no artificial flavors or colors, and no caffeine. The powder mixes in Chocolate, Vanilla, and Strawberry flavors can only be purchased on line. To learn more about NuVim® visit www.nuvim.com or call toll free 877-850-8777.

NUVIM BUSINESS UPDATE
August 24, 2010

Progress underway on NuVim’s revitalization

The initial steps of revitalization for NuVim have produced excellent results. During the past month, actions have resulted in significantly improving NuVim’s balance sheet, with reduction of total debt by $1.9 million. With pending investment within the next 30 days, additional debt reduction of $500,000 – $700,000 is forecast by NuVim management.

Read the rest of this entry »

Podcast: Download (Duration: 15:38 — 14.3MB)

Car Charging Group CEO Michael D. Farkas called into SmallCapVoice.com to explain that Car Charging Group, Inc. (OTCBB: CCGI) is an owner and provider of electric vehicle (EV) charging stations with the mission to build-out a nationwide infrastructure, enabling EV and PHEV owners to charge their EVs anytime, anywhere. As part of its strategy, the Company owns, provides, installs and maintains electric vehicle charging units and works with its landowner partners to identify appropriate locations for its charging stations. The Company seeks to provide convenient, safe and affordable charging stations away from home in customer-friendly public locations, including parking garages, municipalities, and shopping malls.

Podcast: Download (Duration: 11:48 — 10.8MB)

Nadav Kidron, Oramed’s CEO called into SmallCapVoice.com to explain that Oramed Pharmaceuticals Inc. (OTCBB: ORMP) is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed’s technology is based on over 25 years of research by top research scientists at Jerusalem’sHadassah Medical Center. The Company’s corporate and R&D headquarters are based in Jerusalem.

Podcast: Download (Duration: 20:07 — 18.4MB)

Patrick Smith, CEO of Curaxis Pharmaceutical Corp. (OTCBB: ASCH) called into SmallCapVoice.com to explain how Curaxis Pharmaceutical is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer’s disease and multiple cancers. Curaxis’ therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer’s disease and various cancers. We believe our discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer’s patients and in multiple tumors will enable us to develop significant new treatments for Alzheimer’s disease as well as many cancers.

Podcast: Download (Duration: 13:53 — 12.7MB)

Norman Knowles, President and CEO, Convenience TV Inc. (OTC.BB: CRPZ) called into SmallCapVoice.com to discuss how Convenience TV is focused on the Convenience Store Industry and provides their clients with an “in-location” TV network. The Network is designed to deliver both entertaining content and targeted advertising on a demographic basis to each retail location. In addition, the Network delivers promotional advertising tied to products within the retail location. The programming can be up-dated quickly and is tailored to meet the specific client’s need for increased sales, customer enjoyment and brand reinforcement.